Hainan Shuangcheng Pharmaceuticals Co., Ltd. (SHE:002693)

SHE:002693 Revenue

In the year 2025, Hainan Shuangcheng Pharmaceuticals had annual revenue of 276.76M CNY with 58.87% growth. Hainan Shuangcheng Pharmaceuticals had revenue of 107.86M in the quarter ending December 31, 2025, with 128.29% growth.

• Revenue: 276.76M
• Revenue Growth: +58.87%
• P/S Ratio: 12.86
• Revenue / Employee: 457.46K
• Employees: 605
• Market Cap: 3.56B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	276.76M	102.56M	58.87%
Dec 31, 2024	174.21M	-61.72M	-26.16%
Dec 31, 2023	235.93M	-38.82M	-14.13%
Jan 1, 2023	274.75M	-45.54M	-14.22%
Jan 1, 2022	320.29M	50.85M	18.87%

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Apr 29, 2026

Data Sources Report a data error